GB9102997D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9102997D0
GB9102997D0 GB919102997A GB9102997A GB9102997D0 GB 9102997 D0 GB9102997 D0 GB 9102997D0 GB 919102997 A GB919102997 A GB 919102997A GB 9102997 A GB9102997 A GB 9102997A GB 9102997 D0 GB9102997 D0 GB 9102997D0
Authority
GB
United Kingdom
Prior art keywords
pct
sec
date
ring
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919102997A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GB919102997A priority Critical patent/GB9102997D0/en
Publication of GB9102997D0 publication Critical patent/GB9102997D0/en
Priority to AT92902889T priority patent/ATE109482T1/de
Priority to RU93054165A priority patent/RU2114845C1/ru
Priority to FI933531A priority patent/FI933531A7/fi
Priority to AU11683/92A priority patent/AU650322B2/en
Priority to EP92902889A priority patent/EP0572425B1/en
Priority to HU9302327A priority patent/HUT65947A/hu
Priority to DK92902889.2T priority patent/DK0572425T3/da
Priority to PCT/EP1992/000163 priority patent/WO1992014734A1/en
Priority to DE69200304T priority patent/DE69200304T2/de
Priority to KR1019930702352A priority patent/KR970005302B1/ko
Priority to US08/087,736 priority patent/US5358953A/en
Priority to ES92902889T priority patent/ES2059212T3/es
Priority to BR9205615A priority patent/BR9205615A/pt
Priority to JP4503504A priority patent/JP2506541B2/ja
Priority to PL92300296A priority patent/PL169304B1/pl
Priority to CA002099381A priority patent/CA2099381C/en
Priority to IL10088792A priority patent/IL100887A/en
Priority to EG8792A priority patent/EG20085A/xx
Priority to TW081100891A priority patent/TW227000B/zh
Priority to MX9200589A priority patent/MX9200589A/es
Priority to YU14392A priority patent/YU48238B/sh
Priority to NZ241597A priority patent/NZ241597A/en
Priority to CS92425A priority patent/CZ280504B6/cs
Priority to ZA921005A priority patent/ZA921005B/xx
Priority to IE920449A priority patent/IE65125B1/en
Priority to MYPI92000223A priority patent/MY108437A/en
Priority to CN92100974A priority patent/CN1040326C/zh
Priority to NO932889A priority patent/NO300592B1/no
Priority to HU95P/P00175P priority patent/HU211202A9/hu
Priority to FI973558A priority patent/FI101225B1/fi
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
GB919102997A 1991-02-13 1991-02-13 Therapeutic agents Pending GB9102997D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents
KR1019930702352A KR970005302B1 (ko) 1991-02-13 1992-01-24 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제
JP4503504A JP2506541B2 (ja) 1991-02-13 1992-01-24 イミダゾピリジンｐａｆ／ｈ▲下１▼拮抗薬
PL92300296A PL169304B1 (pl) 1991-02-13 1992-01-24 Sposób wytwarzania nowych pochodnych imidazopirydyny PL PL
FI933531A FI933531A7 (fi) 1991-02-13 1992-01-24 PAF:n/H1:n imidatsopyridiiniantagonisteja
AU11683/92A AU650322B2 (en) 1991-02-13 1992-01-24 Imidazopyridine PAF/H1 antagonists
EP92902889A EP0572425B1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h 1 antagonists
HU9302327A HUT65947A (en) 1991-02-13 1992-01-24 Imidazo-pyridine - derivatives with paf/h1 antagonist activity and pharmaceutical compositions containing them and process for the production thereof
DK92902889.2T DK0572425T3 (da) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister
PCT/EP1992/000163 WO1992014734A1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h1 antagonists
DE69200304T DE69200304T2 (de) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-Antagonisten.
RU93054165A RU2114845C1 (ru) 1991-02-13 1992-01-24 Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1)
US08/087,736 US5358953A (en) 1991-02-13 1992-01-24 Imidazopyridine PAF/H1 antagonists
ES92902889T ES2059212T3 (es) 1991-02-13 1992-01-24 Antagonistas paf/h1 imidazopiridina.
BR9205615A BR9205615A (pt) 1991-02-13 1992-01-24 Imidazopiridinas antagonistas de PAF/H1.
AT92902889T ATE109482T1 (de) 1991-02-13 1992-01-24 Imidazopyridin-paf/h1-antagonisten.
CA002099381A CA2099381C (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h _antagonists
IL10088792A IL100887A (en) 1991-02-13 1992-02-06 Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing them
EG8792A EG20085A (en) 1991-02-13 1992-02-10 Process for preparing of imidazopyridine PAF/H2 antagonists
TW081100891A TW227000B (enExample) 1991-02-13 1992-02-10
MX9200589A MX9200589A (es) 1991-02-13 1992-02-11 Imidazopiridinas antagonistas de fap/h1. imidazopiridinas antagonistas de fap/h1.
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists
IE920449A IE65125B1 (en) 1991-02-13 1992-02-12 Imidazopyridine PAF/H1 antagonists
NZ241597A NZ241597A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h 1 antagonists
CS92425A CZ280504B6 (cs) 1991-02-13 1992-02-12 Imidazopyridinové deriváty jako antagonisty PAF/H1, způsob přípravy těchto sloučenin a použití
ZA921005A ZA921005B (en) 1991-02-13 1992-02-12 Imidazopyridine PAF/H 1 antagonists.
YU14392A YU48238B (sh) 1991-02-13 1992-02-12 Derivti imidazopiridina, postupak za dobijanje smeša sa njima i postupak za dobijanje derivata imidazopiridina
CN92100974A CN1040326C (zh) 1991-02-13 1992-02-13 咪唑并吡啶paf/h1拮抗剂的制备方法
NO932889A NO300592B1 (no) 1991-02-13 1993-08-13 Imidazopyridin PAF/H1 antagonister
HU95P/P00175P HU211202A9 (en) 1991-02-13 1995-06-09 Imidazopyridine paf/h 1 antagonists
FI973558A FI101225B1 (fi) 1991-02-13 1997-08-29 Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso[4,5-c]pyrid-1-yylijohdannaisten valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9102997D0 true GB9102997D0 (en) 1991-03-27

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919102997A Pending GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
WO1996005201A1 (en) * 1994-08-10 1996-02-22 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
CA3050734A1 (en) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CN101932575B (zh) 2008-01-30 2013-06-12 日本脏器制药株式会社 哌啶衍生物
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
CA2846394A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
DE68920998T2 (de) * 1988-03-15 1995-06-22 Searle & Co 1H/3H-[4-(N,N-CYCLOALKYL UND/ODER VERZWEIGTES ALKYLCARBOXAMIDO)-BENZYL]IMDAZO[4,5-c]PYRIDINE ALS PAF-ANTAGONISTEN.
EP0339978B1 (en) * 1988-04-28 1996-08-21 Schering Corporation Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
BR9106433A (pt) * 1990-05-09 1993-05-04 Pfizer Imidazo (4,5-c) piridinas com atividade antagonista ao paf

Also Published As

Publication number Publication date
JP2506541B2 (ja) 1996-06-12
NO932889L (no) 1993-08-13
MX9200589A (es) 1992-10-01
JPH06504992A (ja) 1994-06-09
CS42592A3 (en) 1992-09-16
NO300592B1 (no) 1997-06-23
PL169304B1 (pl) 1996-06-28
AU1168392A (en) 1992-09-15
IE65125B1 (en) 1995-10-04
CZ280504B6 (cs) 1996-02-14
NO932889D0 (no) 1993-08-13
EG20085A (en) 1997-05-31
NZ241597A (en) 1993-04-28
IE920449A1 (en) 1992-08-12
TW227000B (enExample) 1994-07-21
BR9205615A (pt) 1994-05-17
YU14392A (sh) 1994-11-15
DE69200304T2 (de) 1994-12-08
ATE109482T1 (de) 1994-08-15
CA2099381C (en) 1996-07-09
DE69200304D1 (de) 1994-09-08
ZA921005B (en) 1993-08-12
HUT65947A (en) 1994-08-29
FI933531L (fi) 1993-08-10
WO1992014734A1 (en) 1992-09-03
YU48238B (sh) 1997-08-22
RU2114845C1 (ru) 1998-07-10
CA2099381A1 (en) 1992-08-14
EP0572425B1 (en) 1994-08-03
IL100887A (en) 1996-01-19
AU650322B2 (en) 1994-06-16
ES2059212T3 (es) 1994-11-01
FI933531A0 (fi) 1993-08-10
US5358953A (en) 1994-10-25
DK0572425T3 (da) 1994-09-12
CN1040326C (zh) 1998-10-21
EP0572425A1 (en) 1993-12-08
HU211202A9 (en) 1995-11-28
HU9302327D0 (en) 1993-10-28
FI933531A7 (fi) 1993-08-10
MY108437A (en) 1996-09-30
KR970005302B1 (ko) 1997-04-15
CN1064275A (zh) 1992-09-09
IL100887A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
TW227000B (enExample)
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
FI954678A0 (fi) Keinotekoiset lasimaiset kuidut
NO942758L (no) Benzopyraner og beslektede LTB4 antagonister
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
ES2110260T3 (es) Androstenonas.
DE69403084D1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
SG164268A1 (en) Quinolin-4-yl derivatives i
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
DE69014903D1 (de) Disubstituierte piperidine und pyrrolidine als anticholinergische mittel.
MY102440A (en) Fungicidal pyridyl cyclopropane carboxamides.
DE3484375D1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
ATE514420T1 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und endothelinantagonisten
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
ATE110367T1 (de) Kalziumantagonisten.
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür